Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOBR Safe (SOBR) Asset Writedowns and Impairment (2020 - 2025)

SOBR Safe has reported Asset Writedowns and Impairment over the past 4 years, most recently at $6713.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 73.21% to $6713.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $16203.0, a 35.86% decrease, with the full-year FY2025 number at $16203.0, down 35.86% from a year prior.
  • Asset Writedowns and Impairment reached $6713.0 in Q4 2025 per SOBR's latest filing, down from $9490.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $25058.0 in Q4 2024, with the low at $202.0 in Q1 2024.
  • The 3-year median for Asset Writedowns and Impairment is $1992.0 (2023), against an average of $6369.6.
  • The largest YoY upside for Asset Writedowns and Impairment was 1157.93% in 2024 against a maximum downside of 77.1% in 2024.
  • Tracing SOBR's Asset Writedowns and Impairment over 3 years: stood at $1992.0 in 2023, then soared by 1157.93% to $25058.0 in 2024, then tumbled by 73.21% to $6713.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $6713.0, $9490.0, and $25058.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.